REG - Citadel Group Sanofi SA - Form 8.3 - Horizon Therapeutics PLC
01/12/2022 15:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221201:nRSA3173Ia&default-theme=true
RNS Number : 3173I Citadel Group 01 December 2022
Ap 19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Citadel Group
Company dealt in HORIZON THERAPEUTICS PLC
Class of relevant security to which the dealings being disclosed relate (Note Common Stock ISIN IE00BQPVQZ61
2)
Date of dealing 30 November, 2022
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security
dealt in (Note 3)
Long Short
ISIN IE00BQPVQZ61 Number (%) Number (%)
(1) Relevant securities 2,834,911 (1.25%) 218,765 (0.09%)
(2) Derivatives (other than options) 0 (0.00%) 77,000 (0.03%)
(3) Options and agreements to purchase/sell 161,542 (0.07%) 32,461 (0.01%)
Total 2,996,453 (1.32%) 328,226 (0.14%)
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)
ISIN IE00BQPVQZ61
Buy Transaction 8,358 100.2900 USD
Buy Transaction 4,469 99.9095 USD
Buy Transaction 1,200 99.6762 USD
Buy Transaction 955 99.8898 USD
Buy Transaction 422 100.2855 USD
Buy Transaction 400 100.2356 USD
Buy Transaction 160 100.0000 USD
Buy Transaction 100 99.4253 USD
Buy Transaction 78 100.8400 USD
Buy Transaction 25,589 103.2328 USD
Buy Transaction 14,052 103.7035 USD
Buy Transaction 9,708 101.9760 USD
Buy Transaction 9,544 104.9656 USD
Buy Transaction 5,268 103.7035 USD
Buy Transaction 3,883 101.9759 USD
Buy Transaction 1,941 101.9759 USD
Buy Transaction 1,456 101.9756 USD
Sell Transaction 8,358 100.2900 USD
Sell Transaction 111,600 99.8989 USD
Sell Transaction 8,365 100.2900 USD
Sell Transaction 35 100.2900 USD
Sell Transaction 2,342 100.2900 USD
Sell Transaction 100 99.7600 USD
Sell Transaction 100 99.5500 USD
Sell Transaction 600 100.0000 USD
Sell Transaction 825 100.6312 USD
Sell Transaction 1,704 101.0020 USD
Sell Transaction 1,837 100.5807 USD
Sell Transaction 4,280 100.5964 USD
Sell Transaction 8,291 100.3112 USD
Sell Transaction 19,497 99.8718 USD
Sell Transaction 3,008 100.3997 USD
Sell Transaction 18,015 100.1262 USD
Sell Transaction 23,117 100.8605 USD
Sell Transaction 25,287 100.5207 USD
Sell Transaction 57,876 100.2161 USD
Sell Transaction 1,365 100.4853 USD
Sell Transaction 2,231 101.0959 USD
Sell Transaction 2,421 99.7575 USD
Sell Transaction 2,693 99.8513 USD
Sell Transaction 2,900 99.8679 USD
Sell Transaction 4,550 100.3112 USD
Sell Transaction 6,687 99.7991 USD
Sell Transaction 100 100.0400 USD
Sell Transaction 200 100.0400 USD
Sell Transaction 400 99.9213 USD
Sell Transaction 572 99.9153 USD
Sell Transaction 696 100.2900 USD
Sell Transaction 1,300 100.0127 USD
Sell Transaction 2,338 100.2900 USD
Sell Transaction 2,462 100.2900 USD
Sell Transaction 2,587 100.2900 USD
Sell Transaction 3,300 100.0229 USD
Sell Transaction 5,591 99.8804 USD
Sell Transaction 6,549 101.1905 USD
Sell Transaction 6,774 100.3607 USD
Sell Transaction 7,000 100.0227 USD
Sell Transaction 7,698 100.2900 USD
Sell Transaction 11,507 100.0115 USD
Sell Transaction 12,367 100.3997 USD
Sell Transaction 200 101.7600 USD
Sell Transaction 460 100.4853 USD
Sell Transaction 1,639 100.7851 USD
DVP Transaction 641 100.2900 USD
DVP Transaction 7,954 100.2900 USD
DVP Transaction 8,358 100.2900 USD
DVP Transaction 10,700 100.2900 USD
RVP Transaction 16,716 100.2900 USD
RVP Transaction 7,954 100.2900 USD
RVP Transaction 2,342 100.2900 USD
RVP Transaction 641 100.2900 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
ISIN IE00BQPVQZ61
(c) Options transactions in respect of existing relevant
securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option Writing, selling, purchasing, Number of securities to which the option relates (Note 7) Exercise price Type, Expiry date Option money paid/ received per unit
varying etc. e.g. American, European etc. (Note 5)
(ii) Exercising
Product name, Number of securities Exercise price per unit
e.g. call option (Note 5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Name of person dealing (Note 1) Citadel Group
Company dealt in HORIZON THERAPEUTICS PLC
Class of relevant security to which the dealings being disclosed relate (Note Common Stock ISIN IE00BQPVQZ61
2)
Date of dealing 30 November, 2022
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security
dealt in (Note 3)
Long Short
ISIN IE00BQPVQZ61 Number (%) Number (%)
(1) Relevant securities 2,834,911 (1.25%) 218,765 (0.09%)
(2) Derivatives (other than options) 0 (0.00%) 77,000 (0.03%)
(3) Options and agreements to purchase/sell 161,542 (0.07%) 32,461 (0.01%)
Total 2,996,453 (1.32%) 328,226 (0.14%)
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)
ISIN IE00BQPVQZ61
Buy Transaction 8,358 100.2900 USD
Buy Transaction 4,469 99.9095 USD
Buy Transaction 1,200 99.6762 USD
Buy Transaction 955 99.8898 USD
Buy Transaction 422 100.2855 USD
Buy Transaction 400 100.2356 USD
Buy Transaction 160 100.0000 USD
Buy Transaction 100 99.4253 USD
Buy Transaction 78 100.8400 USD
Buy Transaction 25,589 103.2328 USD
Buy Transaction 14,052 103.7035 USD
Buy Transaction 9,708 101.9760 USD
Buy Transaction 9,544 104.9656 USD
Buy Transaction 5,268 103.7035 USD
Buy Transaction 3,883 101.9759 USD
Buy Transaction 1,941 101.9759 USD
Buy Transaction 1,456 101.9756 USD
Sell Transaction 8,358 100.2900 USD
Sell Transaction 111,600 99.8989 USD
Sell Transaction 8,365 100.2900 USD
Sell Transaction 35 100.2900 USD
Sell Transaction 2,342 100.2900 USD
Sell Transaction 100 99.7600 USD
Sell Transaction 100 99.5500 USD
Sell Transaction 600 100.0000 USD
Sell Transaction 825 100.6312 USD
Sell Transaction 1,704 101.0020 USD
Sell Transaction 1,837 100.5807 USD
Sell Transaction 4,280 100.5964 USD
Sell Transaction 8,291 100.3112 USD
Sell Transaction 19,497 99.8718 USD
Sell Transaction 3,008 100.3997 USD
Sell Transaction 18,015 100.1262 USD
Sell Transaction 23,117 100.8605 USD
Sell Transaction 25,287 100.5207 USD
Sell Transaction 57,876 100.2161 USD
Sell Transaction 1,365 100.4853 USD
Sell Transaction 2,231 101.0959 USD
Sell Transaction 2,421 99.7575 USD
Sell Transaction 2,693 99.8513 USD
Sell Transaction 2,900 99.8679 USD
Sell Transaction 4,550 100.3112 USD
Sell Transaction 6,687 99.7991 USD
Sell Transaction 100 100.0400 USD
Sell Transaction 200 100.0400 USD
Sell Transaction 400 99.9213 USD
Sell Transaction 572 99.9153 USD
Sell Transaction 696 100.2900 USD
Sell Transaction 1,300 100.0127 USD
Sell Transaction 2,338 100.2900 USD
Sell Transaction 2,462 100.2900 USD
Sell Transaction 2,587 100.2900 USD
Sell Transaction 3,300 100.0229 USD
Sell Transaction 5,591 99.8804 USD
Sell Transaction 6,549 101.1905 USD
Sell Transaction 6,774 100.3607 USD
Sell Transaction 7,000 100.0227 USD
Sell Transaction 7,698 100.2900 USD
Sell Transaction 11,507 100.0115 USD
Sell Transaction 12,367 100.3997 USD
Sell Transaction 200 101.7600 USD
Sell Transaction 460 100.4853 USD
Sell Transaction 1,639 100.7851 USD
DVP Transaction 641 100.2900 USD
DVP Transaction 7,954 100.2900 USD
DVP Transaction 8,358 100.2900 USD
DVP Transaction 10,700 100.2900 USD
RVP Transaction 16,716 100.2900 USD
RVP Transaction 7,954 100.2900 USD
RVP Transaction 2,342 100.2900 USD
RVP Transaction 641 100.2900 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
ISIN IE00BQPVQZ61
(c) Options transactions in respect of existing relevant
securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option Writing, selling, purchasing, Number of securities to which the option relates (Note 7) Exercise price Type, Expiry date Option money paid/ received per unit
varying etc. e.g. American, European etc. (Note 5)
(ii) Exercising
Product name, Number of securities Exercise price per unit
e.g. call option (Note 5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap 21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure: 01 December, 2022
Contact name: Paula Sharp
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated
None
Is a Supplemental Form 8 attached? (Note 9)
NO
Date of disclosure: 01 December, 2022
Contact name: Paula Sharp
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ISEUPGPUPUPPGAGRecent news on Sanofi SA
See all newsREG - Deutsche Bank AG FF - Pre Stabilisation Notice - Sanofi 2yr FRN & 6y FXD
AnnouncementREG - Stock Exch Notice - Admission to ISM - 14/02/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 17/09/2024
AnnouncementREG - Stock Exch Notice - Admission to ISM - 17/06/2024
AnnouncementRCS - Issuer Direct NEWCO - Ad Scientiam Launches Study to Assess MSCopilot
Announcement